ATRA

Atara Biotherapeutics, Inc. ATRA

ATRA
Atara Biotherapeutics, Inc. MGNX
MacroGenics, Inc. ATYR
aTyr Pharma, Inc. CNTB
Connect Biopharma Holdings Limited SRZN
Surrozen, Inc. QNCX
Quince Therapeutics, Inc. SPRB
Spruce Biosciences, Inc. BMEA
Biomea Fusion, Inc. ANEB
Anebulo Pharmaceuticals, Inc. MGX
Metagenomi, Inc. Common Stock

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ATRA MGNX ATYR CNTB SRZN QNCX SPRB BMEA ANEB MGX
6M 147.08 % 34.13 % -67.74 % 147.56 % 39.49 % 94.85 % 135 258.69 % -5.92 % 149.50 % 119.08 %
YTD 7.66 % -48.79 % -74.42 % 51.24 % -4.56 % 2.66 % 38 192.83 % -56.91 % 59.49 % -12.14 %
1Y 62.53 % -57.96 % -62.26 % 47.58 % 39.34 % 143.41 % 31 395.22 % -86.08 % 37.70 % 67.34 %
3Y -84.72 % -57.32 % -42.20 % 99.13 % -60.75 % 78.70 % 13 285.47 % -82.90 % -3.08 % -67.70 %
5Y -95.57 % -92.84 % -42.20 % -90.10 % -91.03 % -96.19 % 888.70 % -90.65 % -64.51 % -67.70 %
10Y -97.96 % -94.23 % -42.20 % -90.10 % -91.03 % -94.13 % 844.57 % -90.65 % -64.51 % -67.70 %
From the beginning -94.27 % -93.24 % -42.20 % -90.10 % -91.03 % -94.13 % 844.57 % -90.65 % -64.51 % -67.70 %

Dividend